Harlan F. Weisman's Insider Trades & SAST Disclosures
Harlan F. Weisman's most recent trade in Tff Pharmaceuticals Inc was a trade of 27,480 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on July 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Harlan F. Weisman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 27,480 | 27,480 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 27,480 | 842,095 (4%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 44,967 | 44,967 | - | - | Restricted stock units | |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 600,000 | 814,615 (4%) | 3% | 0.3 | 150,000 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 10 Mar 2023 | 150,000 | 214,615 (1%) | 0% | 0.9 | 131,835 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 15 Dec 2022 | 50,000 | 64,615 (0%) | 0% | 1.1 | 53,000 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2022 | 1,792,450 | 1,792,450 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 18 May 2022 | 4,615 | 14,615 (0%) | 0% | 5.5 | 25,383 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director | Purchase of securities on an exchange or from another person at price $ 5.12 per share. | 18 May 2022 | 2,500 | 10,000 (0%) | 0% | 5.1 | 12,800 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director | Purchase of securities on an exchange or from another person at price $ 4.74 per share. | 16 May 2022 | 2,500 | 7,500 (0%) | 0% | 4.7 | 11,850 | Common Stock |
| Tff Pharmaceuticals Inc | Harlan F. Weisman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 20,000 | 159,429 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges